EVOGENE LTD (EVGN)

IL0011050551 - Common Stock

0.71  +0 (+0.64%)

After market: 0.6951 -0.01 (-2.1%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
930K
-10.58%		1.68M
80.65%		5.64M
235.71%		17.34M
207.45%
EBITDA
YoY % growth
-28.63M
-29.66%		-27.74M
3.11%		-23.912M
13.80%		-18.054M
24.50%
EBIT
YoY % growth
-30.86M
-24.39%		-30.32M
1.75%		-26.524M
12.52%		-23.384M
11.84%
Operating Margin
-3,318.28%-1,804.76%-470.28%-134.85%
EPS
YoY % growth
-0.69-0.64
7.25%		-0.53
17.19%		-0.43
18.21%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.10
35.40%
Revenue
Q2Q % growth		3.57M
457.81%
EBITDA
Q2Q % growth		-3.621MN/AN/AN/AN/A
EBIT
Q2Q % growth		-4.947M
27.25%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.13
-85.71%		-0.140.018.96%
Q3 2023
Q2Q % growth		 -0.08
50.00%		-0.160.0849.94%
Q2 2023
Q2Q % growth		 -0.17
19.05%		-0.180.014.76%
Q1 2023
Q2Q % growth		 -0.15
25.00%		-0.160.018.09%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 578K
-12.42%		510K68K13.33%
Q3 2023
Q2Q % growth		 3.767M
701.49%		1.204M2.563M212.87%
Q2 2023
Q2Q % growth		 650K
109.68%		902.7K-252.7K-27.99%
Q1 2023
Q2Q % growth		 640K
166.67%		887.4K-247.4K-27.88%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -78.14% -13.84% -26.24%
Revenue0% -65.44% -44.88% -44.88%